Clinical Edge Journal Scan

RA: Higher rehabilitation dose improves patient-reported physical function in real world


 

Key clinical point: Higher rehabilitation dose (>8 physical/occupational therapy visits) improved physical function in adults with rheumatoid arthritis (RA) who reported new rehabilitation visits after at least 1 year without rehabilitation visits.

Major finding: Worse physical function at baseline was associated with a higher rehabilitation dose (adjusted odds ratio [aOR] 1.29; 95% CI 1.04-1.60). Higher vs. lower rehabilitation dose was also associated with clinically favorable changes in physical function (aOR 1.41; 95% CI 1.03-1.92).

Study details: This prospective cohort analysis evaluated the data of 1,381 adults with RA from the FORWARD registry who reported new rehabilitation visits of low/medium/high dose over 6 months after no rehabilitation visits for past 1 year.

Disclosures: This study did not receive any specific funding. LM Thoma and E Wellsandt reported receiving support from the Rheumatology Research Foundation and/or National Institutes of Health.

Source: Thoma LM et al. Examining rehabilitation dose in adults with rheumatoid arthritis: Association with baseline factors and change in clinical outcomes. Arthritis Care Res (Hoboken). 2022 (Sep 12). Doi: 10.1002/acr.25019

Recommended Reading

Ten-day methotrexate pause after COVID vaccine booster enhances immunity against Omicron variant
MDedge Rheumatology
Increased risk for severe COVID-19 in rheumatoid arthritis and its phenotypic subgroups
MDedge Rheumatology
RA in remission: Subclinical inflammation lower with cs/bDMARDs combination vs. monotherapy
MDedge Rheumatology
Withdrawing methotrexate increased disease activity without affecting remission rates in RA patients at target
MDedge Rheumatology
RA: Increased risk for VTE with JAK inhibitors
MDedge Rheumatology
Suboptimal early RA management predicts difficult-to-treat RA
MDedge Rheumatology
Smoking worsens disease outcomes in RA
MDedge Rheumatology
Patients with RA remain at higher risk for SARS-CoV-2 infection and severe outcomes
MDedge Rheumatology
RA: High serum IFNβ levels predict early relapse after bDMARD withdrawal
MDedge Rheumatology
Osteoporosis remains highly prevalent in patients with RA
MDedge Rheumatology